Medicamen Biotech Limited — Board Meeting, 25-04-2025: Outcome of Board Meeting

Medicamen Biotech Limited has announced a board meeting outcome where the Board approved the allotment of 8,48,220 equity shares at an issue price of Rs. 530 each, raising up to ₹44.96 crore. Additionally, up to 6,50,000 fully convertible warrants were allotted, also at Rs. 530, for up to ₹34.45 crore. This brings the company's paid-up equity share capital to ₹13.56 crore, comprising 1,35,62,820 equity shares. These decisions were made to enhance capital for operational growth.